Literature DB >> 29590536

Alteration of DACH1 methylation patterns in lung cancer contributes to cell proliferation and migration.

Yongjie Feng1, Lin Wang2, Mingyong Wang3.   

Abstract

Lung cancer is the most common cause of cancer-related death. Non-small cell lung cancer (NSCLC) accounts for 80%-85% of total lung cancer cases. Dachshund homolog 1 (DACH1), is a protein encoded by the DACH1 gene in humans. DACH1 inhibits lung adenocarcinoma invasion and tumor growth but has a lower expression in NSCLC. To investigate the mechanisms of decreased DACH1 expression, its DNA methylation patterns were investigated. The results showed a higher methylation rate in NSCLC compared with the adjacent normal lung tissues. Cell transfection experiments showed that increased methylation impaired transcription factor transactivation. In vivo demethylation treatment and overexpression of DACH1 increased apoptosis and decreased migration and invasion in NSCLC A549 cells. Our research provides new insight into NSCLC pathogenesis and identifies a new therapeutic target.

Entities:  

Keywords:  A549 cells; CPNPC; DACH1; DNA methylation; NSCLC; cellules A549; méthylation d’ADN

Mesh:

Substances:

Year:  2018        PMID: 29590536     DOI: 10.1139/bcb-2017-0279

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  3 in total

1.  The clinical significance of HOXA9 promoter hypermethylation in head and neck squamous cell carcinoma.

Authors:  Chongchang Zhou; Jinyun Li; Qun Li; Huigao Liu; Dong Ye; Zhenhua Wu; Zhisen Shen; Hongxia Deng
Journal:  J Clin Lab Anal       Date:  2019-03-06       Impact factor: 2.352

Review 2.  Epigenetic heterogeneity in cancer.

Authors:  Mingzhou Guo; Yaojun Peng; Aiai Gao; Chen Du; James G Herman
Journal:  Biomark Res       Date:  2019-10-31

3.  Diagnostic and Prognostic Value of DACH1 Methylation in the Sensitivity of Esophageal Cancer to Radiotherapy.

Authors:  Jing Huang; Weiguo Zhu; Wanwei Wang; Yingying Xu; Lei Jiang; Zhenlin Gu
Journal:  Contrast Media Mol Imaging       Date:  2022-09-29       Impact factor: 3.009

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.